Efficacy and Safety of Anlotinib and PD-1/L1 Inhibitors as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer Patients who Have Achieved Stable-Disease After First-Line Treatment with Chemotherapy and Immunotherapy: A Retrospective Study

Efficacy and Safety of Anlotinib and PD-1/L1 Inhibitors as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer Patients who Have Achieved Stable-Disease After First-Line Treatment with Chemotherapy and Immunotherapy: A Retrospective Study

Objective To develop personalized treatment strategies for maintenance therapy in patients with extensive-stage small cell lung cancer (ES-SCLC). Materials and Methods We analyzed data from ES-SCLC patients who achieved stable disease (SD) following initial chemotherapy combined with immunotherapy....

Full description

Saved in:
Bibliographic Details
Main Authors: Yi Peng MD, De Wu MD, Jing Tang MD, Xiaobing Li MD
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/10732748251318383
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items